Prevalence and associations of VTE in patients with newly diagnosed lung cancer

Chest

Volumn 146, Issue 3, 2014, Pages 650-658

  Zhang, Yuhui ^a   Yang, Yuanhua ^a   Chen, Wenhui ^a   Guo, Lijuan ^a   Liang, Lirong ^a   Zhai, Zhenguo ^a   Wang, Chen ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; CARCINOEMBRYONIC ANTIGEN; BIOLOGICAL MARKER;

ADULT; AGED; ANEMIA; ANTICOAGULANT THERAPY; ARTICLE; BLOOD CELL COUNT; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISTANT METASTASIS; FEMALE; HUMAN; LEG THROMBOSIS; LEUKOCYTOSIS; LUNG ADENOCARCINOMA; LUNG CANCER; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; VENOUS THROMBOEMBOLISM; ADENOCARCINOMA; BLOOD; COMPLICATION; LUNG NEOPLASMS; MIDDLE AGED; MORTALITY; PREVALENCE; PULMONARY EMBOLISM; RETROSPECTIVE STUDY; RISK FACTOR; STATISTICAL MODEL; SURVIVAL RATE;

ADENOCARCINOMA; AGED; BIOLOGICAL MARKERS; BLOOD CELL COUNT; CARCINOEMBRYONIC ANTIGEN; FEMALE; HUMANS; LOGISTIC MODELS; LUNG NEOPLASMS; MALE; MIDDLE AGED; PREVALENCE; PULMONARY EMBOLISM; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE; VENOUS THROMBOEMBOLISM;

EID: 84907199278     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.13-2379     Document Type: Article

References (30)

1. Chew HK, Davies AM, Wun T, Harvey D, Zhou H, White RH. The incidence of venous thromboembolism among patients with primary lung cancer. J Thromb Haemost. 2008; 6 (4): 601-608.
2. Khorana AA, Francis CW, Culakova E, Kuderer NM, Lyman GH. Thromboembolism is a leading cause of death in cancer patients receiving outpatient chemotherapy. J Thromb Haemost. 2007; 5 (3): 632-634.
3. Huang H, Korn JR, Mallick R, Friedman M, Nichols C, Menzin J. Incidence of venous thromboembolism among chemotherapy-treated patients with lung cancer and its association with mortality: a retrospective database study. J Thromb Thrombolysis. 2012; 34 (4): 446-456.
4. Dentali F, Malato A, Ageno W, et al. Incidence of venous thromboembolism in patients undergoing thoracotomy for lung cancer. J Thorac Cardiovasc Surg. 2008; 135 (3): 705-706.
5. Hicks LK, Cheung MC, Ding K, et al. Venous thromboembolism and nonsmall cell lung cancer: a pooled analysis of National Cancer Institute of Canada Clinical Trials Group trials. Cancer. 2009; 115 (23): 5516-5525.
6. Tagalakis V, Levi D, Agulnik JS, Cohen V, Kasymjanova G, Small D. High risk of deep vein thrombosis in patients with non-small cell lung cancer: a cohort study of 493 patients. J Thorac Oncol. 2007; 2 (8): 729-734.
7. Connolly GC, Dalal M, Lin J, Khorana AA. Incidence and predictors of venous thromboembolism (VTE) among ambulatory patients with lung cancer. Lung Cancer. 2012; 78 (3): 253-258.
8. Corrales-Rodriguez L, Blais N. Lung cancer associated venous thromboembolic disease: a comprehensive review. Lung Cancer. 2012; 75 (1): 1-8.
9. Lyman GH, Kuderer NM; American Society of Clinical Oncology. Prevention and treatment of venous thromboembolism among patients with cancer: the American Society of Clinical Oncology Guidelines. Thromb Res. 2010; 125 (suppl 2): S120-S127.
10. Khorana AA. The NCCN Clinical Practice Guidelines on Venous Thromboembolic Disease: strategies for improving VTE prophylaxis in hospitalized cancer patients. Oncologist. 2007; 12 (11): 1361-1370.
11. Brown A. Preventing venous thromboembolism in hospitalized patients with cancer: improving compliance with clinical practice guidelines. Am J Health Syst Pharm. 2012; 69 (6): 469-481.
12. Blais N. Diagnosing, treating, and preventing venous thromboembolism in patients with cancer. Clin J Oncol Nurs. 2008; 12 (6): 869-874.
13. Satoh T, Oki A, Uno K, et al. High incidence of silent venous thromboembolism before treatment in ovarian cancer. Br J Cancer. 2007; 97 (8): 1053-1057.
14. Satoh T, Matsumoto K, Uno K, et al. Silent venous thromboembolism before treatment in endometrial cancer and the risk factors. Br J Cancer. 2008; 99 (7): 1034-1039.
15. Khorana AA, Kuderer NM, Culakova E, Lyman GH, Francis CW. Development and validation of a predictive model for chemotherapy-associated thrombosis. Blood. 2008; 111 (10): 4902-4907.
16. Ay C, Dunkler D, Simanek R, et al. Prediction of venous thromboembolism in patients with cancer by measuring thrombin generation: results from the Vienna Cancer and Thrombosis Study. J Clin Oncol. 2011; 29 (15): 2099-2103.
17. Ay C, Vormittag R, Dunkler D, et al. D-dimer and prothrombin fragment 1 1 2 predict venous thromboembolism in patients with cancer: results from the Vienna Cancer and Thrombosis Study. J Clin Oncol. 2009; 27 (25): 4124-4129.
18. Yarnell JW, Patterson CC, Sweetnam PM, Lowe GD. Haemostatic/infl ammatory markers predict 10-year risk of IHD at least as well as lipids: the Caerphilly collaborative studies. Eur Heart J. 2004; 25 (12): 1049-1056.
19. Connolly GC, Khorana AA, Kuderer NM, Culakova E, Francis CW, Lyman GH. Leukocytosis, thrombosis and early mortality in cancer patients initiating chemotherapy. Thromb Res. 2010; 126 (2): 113-118.
20. Grunnet M, Sorensen JB. Carcinoembryonic antigen (CEA) as tumor marker in lung cancer. Lung Cancer. 2012; 76 (2): 138-143.
21. Blom JW, Osanto S, Rosendaal FR. The risk of a venous thrombotic event in lung cancer patients: higher risk for adenocarcinoma than squamous cell carcinoma. J Thromb Haemost. 2004; 2 (10): 1760-1765.
22. Tesselaar ME, Osanto S. Risk of venous thromboembolism in lung cancer. C urr Opin Pulm Med. 2007; 13 (5): 362-367.
23. Rami-Porta R, Chansky K, Goldstraw P. Updated lung cancer staging system. Future Oncol. 2009; 5 (10): 1545-1553.
24. Zelen M. Keynote address on biostatistics and data retrieval. Cancer Chemother Rep 3. 1973; 4 (2): 31-42.
25. Mason DP, Quader MA, Blackstone EH, et al. Thromboembolism after pneumonectomy for malignancy: an independent marker of poor outcome. J Thorac Cardiovasc Surg. 2006l 131 (3): 711-718.
26. Abdel-Razeq H. Venous thromboembolism prophylaxis for hospitalized medical patients, current status and strategies to improve. Ann Thorac Med. 2010; 5 (4): 195-200.
27. Agnelli G, Bolis G, Capussotti L, et al. A clinical outcome-based prospective study on venous thromboembolism after cancer surgery: the @RISTOS project. Ann Surg. 2006; 243 (1): 89-95.
28. Al Diab AI. Cancer-related venous thromboembolism: insight into underestimated risk factors. Hematol Oncol Stem Cell Ther. 2010; 3 (4): 191-195.
29. Paneesha S, McManus A, Arya R, et al; VERITY Investigators. Frequency, demographics and risk (according to tumour type or site) of cancer-associated thrombosis among patients seen at outpatient DVT clinics. Thromb Haemost. 2010; 103 (2): 338-343.
30. Goodman LR, Stein PD, Matta F, et al. CT venography and compression sonography are diagnostically equivalent: data from PIOPED II. AJR Am J Roentgenol. 2007; 189 (5): 1071-1076.